의대생/전공의와 제약회사의 윤리적 관계
Ethical Issues Concerning the Relationship between Medical Students/Residents and the Pharmaceutical Industry
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The pharmaceutical industry interacts with the medical profession by supporting clinical research and assisting in medical education activities in academic medical centers. Medical students and residents spend years establishing patterns of prescribing and making relationships with pharmaceutical companies. The pharmaceutical industry has a significant presence during residency training, gaining the overall acceptance of trainees, and appears to influence prescribing behavior. Contact with pharmaceutical representatives is common among medical students and residents. Residents acknowledge the potential for industry influence in others, but generally not in themselves, despite evidence that they themselves are influenced as well. The prescriptions written by residents are associated with pharmaceutical representative visits and the availability of samples. A variety of policy and educational guidelines appear to influence residents’ attitudes toward interactions with industry representatives, although data on the long-term effects of these interventions are limited. This article contends that medical training programs can benefit from policies and curricula that teach medical students and residents about the influence of marketing and how to critically evaluate the information they receive from industry representatives.
Abstract
The pharmaceutical industry interacts with the medical profession by supporting clinical research and assisting in medical education activities in academic medical centers. Medical students and residents spend years establishing patterns of prescribing and making relationships with pharmaceutical companies. The pharmaceutical industry has a significant presence during residency training, gaining the overall acceptance of trainees, and appears to influence prescribing behavior. Contact with pharmaceutical representatives is common among medical students and residents. Residents acknowledge the potential for industry influence in others, but generally not in themselves, despite evidence that they themselves are influenced as well. The prescriptions written by residents are associated with pharmaceutical representative visits and the availability of samples. A variety of policy and educational guidelines appear to influence residents’ attitudes toward interactions with industry representatives, although data on the long-term effects of these interventions are limited. This article contends that medical training programs can benefit from policies and curricula that teach medical students and residents about the influence of marketing and how to critically evaluate the information they receive from industry representatives.
참고문헌 (29)
- Adler, L, "The pharmaceutical industry’s influence on chief medical residents", JGIM, 14(2), pp.128~ (1999)
- Bernard L, "Resolving ethical dilemmas", pp.209~212 (2005), Willams & Wilkins
- Boltri JM, "Effect of antihypertensive samples on physician prescribing patterns", Fam Med, 34, pp.729~731 (2002)
- Brotzman GL, "The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities", J Gen Intern Med, 8, pp.130~134 (1993)
- Chren MM, "Physicians’behavior and their interactions with drug companies: a controlled study of physicians who requested additions to a hospital drug formulary", JAMA, 271, pp.684~689 (1994)
- "Code on Interactions with Healthcare Professionals PhRMA 2008"[URL]
- Ferguson RP, "Encounters with pharmaceutical sales representatives among practicing internists", Am J Med, 107, pp.149~152 (1999)
- Hodges B, "Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks", Can Med Assoc J, 153, pp.553~559 (1995)
- The Influence of the Pharmaceutical Industry: Fourth Report of Session 2004-05, "House of Commons Health Committee", 1~126 (2005)
- "Conflict of Interest in Medical Research, Education, and Practice"[URL]
- Keim SM, "Interactions between emergency medicine programs and the pharmaceutical industry", Acad Emerg Med, 11, pp.19~26 (2004)
- Lichstein PR, "Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors", Arch Intern Med, 152, pp.1009~1013 (1992)
- Lurie N, "Pharmaceutical representatives in academic medical centers: interaction with faculty and house staff", JGIM, 5, pp.240~243 (1990)
- McCormick BB, "Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior", JAMA, 286, pp.1994~1999 (2001)
- Montague BT, "A systematic review of curricula on relationships between residents and the pharmaceutical industry", Med Educ, 42, pp.301~308 (2008)
- Orlowski JP, "The effects of pharmaceutical firm enticements on physician prescribing patterns: there’’s no such thing as a free lunch", Chest, 102, pp.270~273 (1992)
- Oxman AD, "No magic bullets: a systematic review of 102 trials of interventions to improve professional practice", Can Med Assoc J, 153, pp.1423~1431 (1995)
- "Code of Interactions with healthcare professionals"[URL]
- Randall ML, "Attitudes and behaviours of psychiatry residents toward pharmaceutical representatives before and after an educational intervention", Acad Psychiatry, 29(1), pp.33~39 (2005)
- Schneider JA, "Residents perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention", Acad Med, 81(7), pp.595~602 (2006)
- Schwartz TL, "Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits", Ann Clin Psychiatry, 13, pp.159~162 (2001)
- Sergeant MD, "Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario", Can Med Assoc J, 155, pp.1243~1248 (1996)
- Sierles, "Medical students’exposure to and attitudes about drug company interactions: a national survey", JAMA, 294, pp.1034~1042 (2005)
- Steinman MA, "Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions", Am J Med, 110, pp.551~557 (2001)
- Tattersal M, "Doctors behaving badly", Med J Aust, 185, pp.299~300 (2006)
- Varley CK, "Benjamin S: A survey of the interactions between psychiatry residency programs and the pharmaceutical", Acad Psychiatry, 29, pp.40~46 (2005)
- Wazana A, "Using the literature in developing McGills guidelines for interactions between residents and the pharmaceutical industry", Acad Med, 79, pp.1033~1040 (2004)
- Ziegler MG, "The accuracy of drug information from pharmaceutical sales representatives", JAMA, 273, pp.1296~1298 (1995)